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The current diagnostic techniques are not effective in
key areas of tuberculosis (TB) research, such as predict-
ing susceptibility, treatment outcome, and monitoring
the effectiveness of drug or vaccine trials. Hence, more
emphasis is to be placed on biomarker research. A bio-
marker is a characteristic feature that is objectively mea-
sured and evaluated as an indicator of a biological or
pathological process or a response to therapy or preven-
tion. Peripheral blood cells may not provide an accurate
picture of what is happening in a TB patient at the site
of disease manifestation, i.e., the granuloma. The fact
that granulomas reach a point where they become lar-
gely autonomous and the immune response controls
itself in the granuloma, has presented challenges. To
address this point, our team infected splenectomized
lymphotoxin b-receptor-deficient mice, which have no
secondary lymphoid organs, with a small dose of Myco-
bacterium tuberculosis (M.tb).W i t h o u tl y m p hn o d e s
and spleen, the mice mounted an immune response and
survived. Upon further analysis, CD8 and CD4 T-cells
were generated in the granulomas as well as central
memory and multifunctional T cells. Mice were then
infected with M.tb, cured with antibiotics and then rein-
fected. When reinfected mice were compared to mice
with a primary infection, we found that protective mem-
ory had developed. We conclude that granulomas can
d e v e l o pa ni m m u n er e s p o n s ei nt h ea b s e n c eo fl y m p h
nodes and spleen. Moreover, in a study of TB lesions in
humans, we found that the same appears to occur.
Using metabolomics, and working with the company
Metabalon, we examined a combination of metabolites
in latently infected individuals and patients with active
TB disease to define a profile to differentiate healthy
infected from diseased individuals. Diagnoses made by
metabolomics profiles were equally accurate as clinical
diagnoses. Metabolomics was also used to identify mar-
kers for cell exhaustion, which can lead to reinfection.
In particular, we studied the metabolite tryptophan, the
degradation of which is involved in suppressive mechan-
isms. These studies were complemented using transcrip-
tomics. Dendritic cells were stimulated with ManLam, a
bacterial cell wall lipid component that binds to DC-
SIGN, a host cell receptor known to be involved in
immunosupression. This binding also caused the cells to
over-express the enzymes involved in the degradation of
tryptophan. We consider this pathway to be involved in
reactivation of TB and sustenance of active disease.
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